Viewing Study NCT05234320


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-04-01 @ 9:52 AM
Study NCT ID: NCT05234320
Status: UNKNOWN
Last Update Posted: 2022-09-22
First Post: 2022-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug
Sponsor: Caregen Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module